Published • loading... • Updated
Business Venture Capital Makes Significant Acquisition in the US.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Enlila Healthcare, a venture capital portfolio company in which Harvard University holds a 10% stake, acquired a 50.1% stake in US-based biotechnology company Crescenta Biosciences for $24 million.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
